datamatters24/research-document-archive huggingface dataset:
I 
114TH CONGRESS 
2D SESSION 
H. R. 4779 
To amend the Controlled Substances Act to prevent Federal prosecutions 
for certain conduct, relating to CBD oil, that is lawful under State 
law, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 17, 2016 
Mr. CHAFFETZ (for himself, Mr. LABRADOR, Mr. COHEN, Mr. CLAY, Mr. 
SENSENBRENNER, and Mr. GROTHMAN) introduced the following bill; 
which was referred to the Committee on the Judiciary, and in addition 
to the Committee on Energy and Commerce, for a period to be subse-
quently determined by the Speaker, in each case for consideration of such 
provisions as fall within the jurisdiction of the committee concerned 
A BILL 
To amend the Controlled Substances Act to prevent Federal 
prosecutions for certain conduct, relating to CBD oil, 
that is lawful under State law, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘CBD Oil Act of 2016’’. 
VerDate Sep 11 2014 
02:40 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4779.IH
H4779
emcdonald on DSK67QTVN1PROD with BILLS
SEC. 2. EXEMPTION FROM CERTAIN CRIMINAL PENALTIES 
OF CONDUCT RELATING TO CBD OIL. 
(a) IN GENERAL.—Part D of the Controlled Sub-
stances Act (21 U.S.C. 801 et seq.) is amended by adding 
at the end the following: 
‘‘BAR TO PROSECUTION OF CERTAIN CONDUCT, RELATING 
TO CBD OIL, THAT IS LAWFUL UNDER STATE LAW 
‘‘SEC. 424. (a) It is a bar to prosecution under this 
title that the conduct alleged to constitute the offense— 
‘‘(1) consists of or is incident to qualified activ-
ity relating to CBD oil; and 
‘‘(2) is lawful under State law in the place it 
occurs. 
‘‘(b) In this section the following definitions apply: 
‘‘(1) The term ‘qualified activity relating to 
CBD oil’ means— 
‘‘(A) the production or distribution of 
CBD oil for medical research; or 
‘‘(B) the use of CBD oil for medical pur-
poses. 
‘‘(2) The term ‘CBD oil’ means a substance, 
not containing any other psychoactive substance, 
that is an extract from a cannabis plant composed 
of tetrahydrocannabinol and cannabidiol in a propor-
tion that is considered nonpsychoactive under appli-
cable State law.’’. 
VerDate Sep 11 2014 
02:40 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4779.IH
H4779
emcdonald on DSK67QTVN1PROD with BILLS
(b) CLERICAL AMENDMENT.—The table of contents 
for the Comprehensive Drug Abuse Prevention and Con-
trol Act of 1970 is amended by inserting after the item 
relating to section 423 the following new item: 
‘‘Sec. 424. Bar to prosecution of certain conduct, relating to CBD oil, that is 
lawful under State law.’’. 
Æ 
VerDate Sep 11 2014 
02:40 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H4779.IH
H4779
emcdonald on DSK67QTVN1PROD with BILLS
screening of persons seeking to enter the United 
States that includes corresponding information for 
each location in which each such program operates. 
(2) The number of Department personnel de-
ployed to each location at which an international 
program referred to in subparagraph (A) is in oper-
ation during the current and preceding fiscal year. 
(3) Analysis of the impact of each international 
program referred to in paragraph (1) on domestic 
activities of components of the Department of 
Homeland Security. 
(4) Analysis of barriers to the expansion of an 
international program referred to in paragraph (1). 
(d) FORM.—The strategy required under subsection 
(a) shall be submitted in unclassified form by may contain 
a classified annex if the Secretary of Homeland Security 
determines that such is appropriate. 
Æ 
VerDate Sep 11 2014 
21:53 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H4780.IH
H4780
asabaliauskas on DSK3SPTVN1PROD with BILLS
I 
114TH CONGRESS 
1ST SESSION 
H. R. 477 
To extend the authority to establish a commemorative work on Federal 
land in the District of Columbia and its environs to honor Brigadier 
General Francis Marion and his service. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 22, 2015 
Mr. WILSON of South Carolina (for himself, Mr. SANFORD, Mr. DUNCAN of 
South Carolina, Mr. GOWDY, Mr. MULVANEY, Mr. CLYBURN, Mr. RICE 
of South Carolina, and Mr. HILL) introduced the following bill; which was 
referred to the Committee on Natural Resources 
A BILL 
To extend the authority to establish a commemorative work 
on Federal land in the District of Columbia and its 
environs to honor Brigadier General Francis Marion and 
his service. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. EXTENSION OF AUTHORITY. 
Notwithstanding section 8903(e) of title 40, United 
States Code, the authority provided by section 331 of the 
VerDate Sep 11 2014 
20:07 Jan 29, 2015
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H477.IH
H477
tkelley on DSK3SPTVN1PROD with BILLS
Consolidated Natural Resources Act of 2008 (Public Law 
110–229) shall continue to apply through May 8, 2018. 
Æ 
VerDate Sep 11 2014 
20:07 Jan 29, 2015
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H477.IH
H477
tkelley on DSK3SPTVN1PROD with BILLS
‘‘(2) PROCEDURE.—Not later than 60 days 
after receipt of a completed application under para-
graph (1), the Secretary shall— 
‘‘(A) approve or deny the application con-
sistent with the requirements of sections 502 
and 503; and 
‘‘(B) notify the applicant of the decision of 
the Secretary and, if the application is denied, 
the reason for the denial. 
‘‘(3) LISTS.— 
‘‘(A) APPLICATIONS.—The Secretary shall 
maintain an updated list of applications pend-
ing, applications approved, and applications de-
nied under this subsection. 
‘‘(B) PORTS.—The Secretary shall main-
tain an updated list of ports through which a 
prescription drug may be imported under this 
section and make the list available to the public 
on an Internet website. 
‘‘(d) PROHIBITION OF IMPORTATION OF A PRESCRIP-
TION DRUG THAT ENTERS OTHER COUNTRIES.— 
‘‘(1) IN GENERAL.—A drug importation facility, 
pharmacy, Internet pharmacy, or wholesaler shall 
not import a prescription drug if, during any period 
in which the prescription drug was not in the control
of the manufacturer, the prescription drug entered a 
country other than— 
‘‘(A) Canada; or 
‘‘(B) subject to paragraph (2), a permitted 
country. 
‘‘(2) LIMITATION.—The Secretary may exclude 
one or more of the countries under subparagraph 
(B) of paragraph (1) from the application of that 
subparagraph if the Secretary determines that allow-
ing a prescription drug to be imported into the 
United States after having entered that country out-
side control of a manufacturer would present a risk 
to the public health. 
‘‘(e) PROHIBITION OF COMMINGLING.— 
‘‘(1) IN GENERAL.—A drug importation facility, 
pharmacy, Internet pharmacy, or wholesaler shall 
not commingle a prescription drug imported into the 
United States under this subchapter with a prescrip-
tion drug that is not imported from Canada or a 
permitted country. 
‘‘(2) LABEL.—A pharmacy or Internet phar-
macy that dispenses a prescription drug imported 
from Canada or a permitted country shall affix on 
each dispensed container of the prescription drug
(b) ANNUAL REPORTS TO THE ADMINISTRATOR RE-
QUIRED TO BE SUBMITTED NOT LATER THAN MARCH 
30 OF EACH YEAR.—Section 9 of the Small Business Act 
(15 U.S.C. 638) is amended— 
(1) in subsection (g)(9), by striking ‘‘make an 
annual report’’ and inserting ‘‘not later than March 
30 of each year, submit a report’’; 
(2) in subsection (i)(1), by striking ‘‘shall re-
port annually to the Small Business Administration’’ 
and inserting ‘‘shall, not later than March 30 of 
each year, submit a report to the Small Business 
Administration that includes’’; 
(3) in subsection (j)— 
(A) in paragraph (1)(E), by striking ‘‘sim-
plified, standardized, and timely annual report’’ 
and inserting ‘‘not later than March 30 of each 
year, a simplified and standardized report’’; and 
(B) in paragraph (3)(C), by striking ‘‘to 
require agencies to report to the Administra-
tion, not less frequently than annually, all in-
stances in which an’’ and inserting ‘‘to require 
each agency, not later than March 30 of each 
year, to submit a report to the Administration 
on all instances in which the’’; 
VerDate Sep 11 2014 
03:10 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4783.IH
H4783
emcdonald on DSK67QTVN1PROD with BILLS
A BILL 
To reauthorize and improve the Small Business Innovation 
Research Program and the Small Business Technology 
Transfer Program, and for other purposes. 
VerDate Sep 11 2014 
20:00 Dec 16, 2016
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6652
E:\BILLS\H4783.RH
H4783
asabaliauskas on DSK3SPTVN1PROD with BILLS
764
HR 2400 EAS
retary of Transportation determines to be rea-
sonable to cover unanticipated cost overruns;
‘‘(ii) each proposed local source of capital
and operating financing is stable, reliable, and
available within the proposed project timetable;
and
‘‘(iii) local resources are available to oper-
ate the overall proposed mass transportation sys-
tem (including essential feeder bus and other
services necessary to achieve the projected rider-
ship levels) without requiring a reduction in ex-
isting mass transportation services to operate the
proposed project.
‘‘(B) In assessing the stability, reliability, and
availability of proposed sources of local financing, the
Secretary of Transportation shall consider—
‘‘(i) existing grant commitments;
‘‘(ii) the degree to which financing sources
are dedicated to the purposes proposed;
‘‘(iii) any debt obligation that exists or is
proposed by the recipient for the proposed project
or other mass transportation purpose; and
‘‘(iv) the extent to which the project has a
local financial commitment that exceeds the re-
224
tions 134 and 135, respectively. Bicycle transportation fa-
cilities and pedestrian walkways shall be considered, where
appropriate, in conjunction with all new construction and
reconstruction of transportation facilities, except where bi-
cycle and pedestrian use are not permitted. Transpor-
tation plans and projects shall provide due consideration
for safety and contiguous routes. Safety considerations
shall include the installation and maintenance of audible
traffic signals and audible signs at street crossings.’’;
(4) in subsection (h) by striking ‘‘No motorized
vehicles shall’’ and inserting ‘‘Motorized vehicles
may not’’;
(5) in subsection (h)(3) by striking ‘‘when State
and local regulations permit,’’;
(6) in subsection (h)—
(A) by striking ‘‘and’’ at the end of para-
graph (3);
(B) by redesignating paragraph (4) as
paragraph (5); and
(C) by inserting after paragraph (3) the
following:
‘‘(4) when State or local regulations permit,
electric bicycles; and’’; and
(7) by striking subsections (i) and (j) and in-
serting the following:
I 
114TH CONGRESS 
2D SESSION 
H. R. 4781 
To amend the Federal Deposit Insurance Act to make certain functions 
of the Federal Deposit Insurance Corporation subject to appropriations. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 17, 2016 
Mr. DUFFY (for himself, Mr. LUETKEMEYER, and Mr. RATCLIFFE) introduced 
the following bill; which was referred to the Committee on Financial Services 
A BILL 
To amend the Federal Deposit Insurance Act to make certain 
functions of the Federal Deposit Insurance Corporation 
subject to appropriations. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘FDIC Accountability 
Act of 2016’’. 
SEC. 2. REQUIREMENT OF APPROPRIATIONS FOR CERTAIN 
FDIC FUNCTIONS. 
(a) IN GENERAL.—Section 10 of the Federal Deposit 
Insurance Act (12 U.S.C. 1820) is amended— 
(1) in subsection (a)— 
VerDate Sep 11 2014 
02:40 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4781.IH
H4781
emcdonald on DSK67QTVN1PROD with BILLS
(A) by striking ‘‘(a) The’’ and inserting 
the following: 
‘‘(a) POWERS.— 
‘‘(1) IN GENERAL.—The’’; 
(B) by inserting ‘‘, subject to paragraph 
(2) and subsection (l),’’ after ‘‘The Board of 
Directors of the Corporation’’; and 
(C) by adding at the end the following new 
paragraph: 
‘‘(2) 
APPROPRIATIONS
REQUIREMENT.—The 
Corporation may only incur obligation or allow and 
pay expenses pursuant to an appropriations Act, 
other than with respect to obligations or expenses 
paid for with funds from the Deposit Insurance 
Fund or incurred, allowed, or paid for the purpose 
of carrying out the insurance function of the Cor-
poration.’’; and 
(2) by adding at the end the following new sub-
section: 
‘‘(l) NON-INSURANCE FEES AS OFFSETTING COL-
LECTIONS.—Any fees collected by the Corporation, except 
pursuant to section 5(d), shall be deposited and credited 
as offsetting collections to the account providing appro-
priations to the Corporation.’’. 
VerDate Sep 11 2014 
02:40 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4781.IH
H4781
emcdonald on DSK67QTVN1PROD with BILLS
(b) EFFECTIVE DATE.—The amendments made by 
this section shall apply with respect to expenses paid and 
fees collected on or after the date that is 90 days after 
the date of the enactment of the first appropriation Act 
that provides for appropriations to the Federal Deposit 
Insurance Corporation and that is enacted after the date 
of the enactment of this Act. 
Æ 
VerDate Sep 11 2014 
02:40 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H4781.IH
H4781
emcdonald on DSK67QTVN1PROD with BILLS
H. R. 2378
One Hundred Fifth Congress
of the
United States of America
AT THE FIRST SESSION
Begun and held at the City of Washington on Tuesday,
the seventh day of January, one thousand nine hundred and ninety-seven
An Act
Making appropriations for the Treasury Department, the United States Postal
Service, the Executive Office of the President, and certain Independent Agencies,
for the fiscal year ending September 30, 1998, and for other purposes.
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled, That the
following sums are appropriated, out of any money in the Treasury
not otherwise appropriated, for the fiscal year ending September
30, 1998, and for other purposes, namely:
TITLE I—DEPARTMENT OF THE TREASURY
DEPARTMENTAL OFFICES
SALARIES AND EXPENSES
For necessary expenses of the Departmental Offices including
operation and maintenance of the Treasury Building and Annex;
hire of passenger motor vehicles; maintenance, repairs, and
improvements of, and purchase of commercial insurance policies
for, real properties leased or owned overseas, when necessary for
the performance of official business; not to exceed $2,900,000 for
official travel expenses; not to exceed $150,000 for official reception
and representation expenses; not to exceed $258,000 for unforeseen
emergencies of a confidential nature, to be allocated and expended
under the direction of the Secretary of the Treasury and to be
accounted for solely on his certificate; $114,771,000: Provided, That
section 113(2) of the Fiscal Year 1997 Department of Commerce,
Justice, and State, the Judiciary, and Related Agencies Appropria-
tions Act, Public Law 104–208 (110 Stat. 3009–22) is amended
by striking ‘‘12 months’’ and inserting in lieu thereof ‘‘2 years’’:
Provided further, That the Office of Foreign Assets Control shall
be funded at no less than $4,500,000: Provided further, That chapter
9 of the fiscal year 1997 Supplemental Appropriations Act for Recov-
ery from Natural Disasters, and for Overseas Peacekeeping Efforts,
including those in Bosnia, Public Law 105–18 (111 Stat. 195–
96) is amended by inserting after the ‘‘County of Denver’’ in each
instance ‘‘the County of Arapahoe’’: Provided further, That $200,000
are provided to conduct a comprehensive study of gambling’s effects
on bankruptcies in the United States: Provided further, That for
necessary expenses of the Office of Enforcement, including, but
not limited to, making transfers of funds to Treasury bureaus
and offices for programs, projects or initiatives directed as the
investigation or prosecution of violent crime, $1,600,000, to remain
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘DHS Stop Asset and 
Vehicle Excess Act’’ or the ‘‘DHS SAVE Act’’. 
SEC. 2. DHS VEHICLE FLEETS. 
Section 701 of the Homeland Security Act of 2002 
(6 U.S.C. 341) is amended— 
(1) in subsection (a)(5), by inserting ‘‘vehicle 
fleets (under subsection (c)),’’ after ‘‘equipment,’’; 
(2) by redesignating subsections (c) and (d) as 
subsections (d) and (e), respectively; and 
(3) by inserting after subsection (b) the fol-
lowing new subsection: 
‘‘(c) VEHICLE FLEETS.— 
‘‘(1) IN GENERAL.—In carrying out responsibil-
ities regarding vehicle fleets pursuant to subsection 
(a)(5), the Under Secretary for Management shall 
be responsible for overseeing and managing vehicle 
fleets throughout the Department. The Under Sec-
retary shall also be responsible for the following: 
‘‘(A) Ensuring that components are in 
compliance with Federal law, Federal regula-
tions, executive branch guidance, and Depart-
ment policy (including issuing guidance relating 
to such) relating to fleet management and use 
of vehicles from home to work.
ments that improve the lives of millions of patients 
in the United States. 
(2) Rising health care costs, including prescrip-
tion drug costs, continue to be a major concern for 
patients in the United States. 
(3) Eighty-eight percent of prescription drugs 
dispensed in the United States, or nearly 9 out of 
every 10 prescriptions dispensed, are generic drugs. 
(4) Studies suggest that generic drugs account 
for only 28 percent of total prescription drug spend-
ing and were responsible for $1,680,000,000,000 in 
estimated savings over the period of 2005 to 2014. 
(5) Increasing generic competition can be an ef-
fective way to help keep prescription drug costs low 
for patients, the health care system, and Federal 
and State government. 
(6) While the Food and Drug Administration 
has made progress toward a more consistent 
timeline for generic drug approvals since the enact-
ment of the Generic Drug User Fee Amendments of 
2012 (21 U.S.C. 379j–41 et seq.), a significant 
backlog of abbreviated new drug applications for ge-
neric drugs remains. 
(7) The sudden, aggressive price hikes for a va-
riety of recently acquired off-patent drugs that have 
VerDate Sep 11 2014 
03:23 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4784.IH
H4784
SSpencer on DSK4SPTVN1PROD with BILLS
been used widely for decades, for which there is no 
generic drug competitor, also affects access to af-
fordable prescriptions for patients and the overall 
cost of health care in the United States. 
(8) Improving the review of abbreviated new 
drug applications and the approval of generic drugs 
would help to improve competition and lower prices 
for patients. 
(9) Establishing a clear timeframe for the Food 
and Drug Administration to expedite the review of 
certain applications for generic drugs would also 
help keep drug prices down and improve timely ac-
cess for patients. 
TITLE 
I—REMOVING 
REGU-
LATORY BARRIERS TO COM-
PETITION 
SEC. 101. IMPROVING GENERIC ACCESS. 
Section 505(j) of the Federal Food, Drug, and Cos-
metic Act (21 U.S.C. 355(j)) is amended by adding at the 
end the following: 
‘‘(11)(A) The Secretary shall prioritize the review, 
and act not later than 180 calendar days after the date 
of the submission of an application, on an application that 
has been submitted and accepted for review under this 
VerDate Sep 11 2014 
03:23 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4784.IH
H4784
SSpencer on DSK4SPTVN1PROD with BILLS
subsection, or on a supplement to such an application, 
that is for a drug that— 
‘‘(i) has been introduced into interstate com-
merce by not more than one manufacturer or spon-
sor, as applicable, in the last 3 months and with re-
spect to which tentative approval under paragraph 
(5) has been granted for not more than 2 applica-
tions; or 
‘‘(ii) has been included on the list under section 
506E. 
‘‘(B) The Secretary may expedite an inspection or re-
inspection under section 704 of an establishment that pro-
poses to manufacture a drug described in subparagraph 
(A).’’. 
SEC. 102. REPORTING ON PENDING GENERIC DRUG APPLI-
CATIONS. 
Not later than 180 calendar days after the date of 
enactment of this Act, and every 180 calendar days there-
after until October 1, 2021, the Secretary of Health and 
Human Services shall submit to the Committee on Health, 
Education, Labor, and Pensions of the Senate, the Special 
Committee on Aging of the Senate, and the Committee 
on Energy and Commerce of the House of Representatives 
a report that provides— 
VerDate Sep 11 2014 
03:23 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4784.IH
H4784
SSpencer on DSK4SPTVN1PROD with BILLS
(1) the number of applications that were filed 
under section 505(j) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 355(j)) prior to October 1, 
2016, that are pending at the time the report is sub-
mitted; 
(2) the average and median total time such ap-
plications have been pending; 
(3) the number of such applications that con-
tain 
certifications 
under 
section 
505(j)(2)(A)(vii)(IV) of such Act; and 
(4) the number of such applications that are 
subject to priority review. 
TITLE II—INCENTIVIZING 
COMPETITION 
SEC. 201. GENERIC PRIORITY REVIEW VOUCHER. 
Chapter V of the Federal Food, Drug, and Cosmetic 
Act (21 U.S.C. 351 et seq.) is amended by inserting after 
section 506F the following: 
‘‘SEC. 506G. GENERIC PRIORITY REVIEW VOUCHER. 
‘‘(a) DEFINITIONS.—In this section: 
‘‘(1) The term ‘priority review’ with respect to 
an application under section 505(j) means review 
and action by the Secretary on such application by 
the Secretary not later than 180 calendar days after 
VerDate Sep 11 2014 
03:23 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H4784.IH
H4784
SSpencer on DSK4SPTVN1PROD with BILLS
such application has been submitted and accepted 
for review. 
‘‘(2) The term ‘priority review voucher’ means 
a voucher for priority review for an application 
under section 505(j). Such voucher shall be awarded 
upon the approval of the application described in 
505(j)(11)(A), unless such application contains a 
certification under section 505(j)(2)(A)(vii)(IV). 
‘‘(b) GENERIC PRIORITY REVIEW VOUCHERS, IN 
GENERAL.—Beginning on October 1, 2017, the Secretary 
shall award a priority review voucher to the sponsor of 
an application described in section 505(j)(11)(A) upon— 
‘‘(1) approval by the Secretary of such applica-
tion; 
‘‘(2) marketing of the drug subject to such ap-
plication; and 
‘‘(3) determination by the Secretary that the 
drug has a sustained market presence. 
‘‘(c) TRANSFERABILITY.— 
‘‘(1) IN GENERAL.—The recipient of a priority 
review voucher under subsection (a) may transfer 
(including by sale) the entitlement to such voucher. 
There is no limit on the number of times a priority 
review voucher may be transferred before such 
voucher is used. 
VerDate Sep 11 2014 
03:23 Mar 18, 2016
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4784.IH
H4784
SSpencer on DSK4SPTVN1PROD with BILLS